CSS
ANIX icon

Cubist Systematic Strategies’s Anixa Biosciences ANIX Stock Holding History

Cubist Systematic Strategies’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,655
Closed -$52K – 2935
2024
Q1 		$52K Buy
+16,655
New +$66.4K ﹤0.01% 3376

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cubist Systematic Strategies's ANIX Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Anixa Biosciences (ANIX) in Q2 2024, closing a stake of 16,655 shares — an estimated $52K sold.

Cubist Systematic Strategies first reported a position in ANIX in Q1 2024 and held it in 1 quarter. The position peaked at $52K in Q1 2024. 53 funds tracked by Wall St. Rank hold ANIX as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Anixa Biosciences position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 16,655 Anixa Biosciences shares in Q2 2024, an estimated $52K.
  • Cubist Systematic Strategies first reported a position in Anixa Biosciences in Q1 2024 and held it in 1 quarter.
  • Cubist Systematic Strategies's Anixa Biosciences position peaked at $52K in Q1 2024.
  • 53 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.